Arcadia Biosciences, Inc. (RKDA) stock
RKDANasdaqBeveragesFiscal year ends December 31
$0.19−0.00 (-2.01%)
Close on Nov 17, 2026Market cap $457.03KP/E –Yield –
Arcadia Biosciences total assets
Total assets on the balance sheet at the end of each period.
Arcadia Biosciences's total assets was $5.89M at Jun 30, 2026. For fiscal 2025 it was $6.55M, down 51.6% from the year before. Over ten years it grew -21.6% a year on average. The highest annual figure on record is $74.24M in fiscal 2015.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.55M | -51.6% |
| FY2024 | Dec 31, 2024 | $13.52M | -31.4% |
| FY2023 | Dec 31, 2023 | $19.71M | -31.9% |
| FY2022 | Dec 31, 2022 | $28.92M | -34.1% |
| FY2021 | Dec 31, 2021 | $43.92M | -7.2% |
| FY2020 | Dec 31, 2020 | $47.35M | +45.4% |
| FY2019 | Dec 31, 2019 | $32.57M | +35.6% |
| FY2018 | Dec 31, 2018 | $24.02M | +45.0% |
| FY2017 | Dec 31, 2017 | $16.57M | -70.7% |
| FY2016 | Dec 31, 2016 | $56.57M | -23.8% |
| FY2015 | Dec 31, 2015 | $74.24M | +198.3% |
| FY2014 | Dec 31, 2014 | $24.89M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.89M | -24.3% |
| Q1 FY2026 | Mar 31, 2026 | $5.32M | -59.0% |
| Q4 FY2025 | Dec 31, 2025 | $6.55M | -51.6% |
| Q3 FY2025 | Sep 30, 2025 | $8.58M | -43.7% |
| Q2 FY2025 | Jun 30, 2025 | $7.79M | -55.2% |
| Q1 FY2025 | Mar 31, 2025 | $12.99M | -19.0% |
| Q4 FY2024 | Dec 31, 2024 | $13.52M | -31.4% |
| Q3 FY2024 | Sep 30, 2024 | $15.24M | -35.1% |
| Q2 FY2024 | Jun 30, 2024 | $17.37M | -35.2% |
| Q1 FY2024 | Mar 31, 2024 | $16.05M | -47.2% |
| Q4 FY2023 | Dec 31, 2023 | $19.71M | -31.9% |
| Q3 FY2023 | Sep 30, 2023 | $23.47M | -31.9% |
| Q2 FY2023 | Jun 30, 2023 | $26.80M | -23.5% |
| Q1 FY2023 | Mar 31, 2023 | $30.41M | -21.6% |
| Q4 FY2022 | Dec 31, 2022 | $28.92M | -34.1% |
| Q3 FY2022 | Sep 30, 2022 | $34.47M | -41.8% |
| Q2 FY2022 | Jun 30, 2022 | $35.01M | -50.6% |
| Q1 FY2022 | Mar 31, 2022 | $38.80M | -45.2% |
| Q4 FY2021 | Dec 31, 2021 | $43.92M | -7.2% |
| Q3 FY2021 | Sep 30, 2021 | $59.23M | +74.8% |
| Q2 FY2021 | Jun 30, 2021 | $70.80M | +87.4% |
| Q1 FY2021 | Mar 31, 2021 | $70.80M | +119.5% |
| Q4 FY2020 | Dec 31, 2020 | $47.35M | +45.4% |
| Q3 FY2020 | Sep 30, 2020 | $33.88M | -9.2% |
| Q2 FY2020 | Jun 30, 2020 | $37.78M | +49.0% |
| Q1 FY2020 | Mar 31, 2020 | $32.25M | +46.9% |
| Q4 FY2019 | Dec 31, 2019 | $32.57M | +35.6% |
| Q3 FY2019 | Sep 30, 2019 | $37.30M | +37.1% |
| Q2 FY2019 | Jun 30, 2019 | $25.35M | -18.6% |
| Q1 FY2019 | Mar 31, 2019 | $21.95M | -2.9% |
| Q4 FY2018 | Dec 31, 2018 | $24.02M | +45.0% |
| Q3 FY2018 | Sep 30, 2018 | $27.22M | +43.4% |
| Q2 FY2018 | Jun 30, 2018 | $31.13M | -35.7% |
| Q1 FY2018 | Mar 31, 2018 | $22.60M | -57.1% |
| Q4 FY2017 | Dec 31, 2017 | $16.57M | -70.7% |
| Q3 FY2017 | Sep 30, 2017 | $18.98M | -69.2% |
| Q2 FY2017 | Jun 30, 2017 | $48.43M | – |
| Q1 FY2017 | Mar 31, 2017 | $52.65M | – |
| Q4 FY2016 | Dec 31, 2016 | $56.57M | – |
| Q3 FY2016 | Sep 30, 2016 | $61.59M | – |
See a number that looks wrong?